TSX Penny Stocks To Watch In July 2026

As the Canadian market navigates a pivotal earnings season, investors are keenly observing trends in AI capex spending and consumer health, with implications for both U.S. and Canadian economies. Amidst this backdrop, penny stocks—often representing smaller or newer companies—remain an intriguing area for potential growth. Despite their name suggesting bygone trading days, these stocks can offer substantial opportunities when backed by strong financials and solid fundamentals.

Underneath we present a selection of stocks filtered out by our screen.

Anaergia (TSX:ANRG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Anaergia Inc. operates globally, offering solutions for renewable energy generation and waste-to-resource conversion, with a market cap of CA$410.42 million.

Operations: The company's revenue streams include CA$19.36 million from O&M Services, CA$178.52 million from Capital Sales, and CA$12.66 million from Build, Own, and Operate activities.

Market Cap: CA$410.42M

Anaergia Inc. has been active in securing significant contracts, such as a CA$14 million project in Australia and an agreement with Vanguard Renewables for an advanced digestion facility in Minnesota. Despite being unprofitable, Anaergia maintains a positive cash flow and has secured a credit facility of up to CA$30 million to enhance liquidity. The company's net debt to equity ratio is high at 58.7%, but it boasts experienced management and board members. Recent revenue growth shows promise, although insider selling raises some concerns about internal confidence levels.

• Navigate through the intricacies of Anaergia with our comprehensive balance sheet health report here.
• Explore Anaergia's analyst forecasts in our growth report.

NexgenRx (TSXV:NXG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: NexgenRx Inc. operates in Canada, providing administration, adjudication, and payment services for drug, dental, and extended health-care claims for health benefit plans, with a market cap of CA$46.94 million.

Operations: The company generates revenue from its benefits administration services, totaling CA$18.45 million.

Market Cap: CA$46.94M

NexgenRx Inc. demonstrates financial stability with short-term assets of CA$36.8 million exceeding both its short and long-term liabilities, while maintaining a debt-free status. The company reported CA$5 million in revenue for Q1 2026, an increase from the previous year, alongside a significant rise in net income to CA$1.23 million. Despite historical earnings declines over five years, recent profit growth of 264.5% indicates positive momentum compared to industry standards. However, high weekly volatility and an unstable dividend track record present risks for investors seeking consistent returns from this penny stock.

• Get an in-depth perspective on NexgenRx's performance by reading our balance sheet health report here.
• Gain insights into NexgenRx's past trends and performance with our report on the company's historical track record.

TDG Gold (TSXV:TDG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: TDG Gold Corp. is involved in the identification, acquisition, exploration, and development of mineral resource projects in Canada with a market cap of CA$117.56 million.

Operations: TDG Gold Corp. has not reported any revenue segments.

Market Cap: CA$117.56M

TDG Gold Corp., with a market cap of CA$117.56 million, is pre-revenue and focused on mineral exploration in Canada. The company has initiated a CA$2.2 million exploration program targeting copper-gold and epithermal gold-silver deposits northwest of its Aurora Complex. Despite being debt-free, TDG faces financial challenges with less than a year of cash runway and increasing losses over the past five years. Recent metallurgical tests at Shasta indicate promising recovery rates for gold and silver, supporting the ongoing Preliminary Economic Assessment aimed at unlocking value from its assets in British Columbia's Toodoggone District.

• Dive into the specifics of TDG Gold here with our thorough balance sheet health report.
• Understand TDG Gold's track record by examining our performance history report.

Key Takeaways

• Explore the 318 names from our TSX Penny Stocks screener here.
• Want To Explore Some Alternatives? These 26 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com